logo
Biological variation in inflammatory and hemostatic markers
Immunoassays are not created equal
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia
Getting intimate with the venous thrombus
Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis
Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram
Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system
Physician compliance with advanced electronic alerts for preventing venous thromboembolism among hospitalized medical patients
Smoking and venous thromboembolism
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study
Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits
Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator
NFκB regulation of platelet function
NF-κB inhibitors impair platelet activation responses
Direct evidence of a native GPVI dimer at the platelet surface
Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets
A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder
Elucidating the role of Staphylococcus epidermidis serine–aspartate repeat protein G in platelet activation
Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency
A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt -targeted transgenic mice
Aspirin reduces the prothrombotic activity of C-reactive protein
After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells
The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome
Assessment of platelet response to clopidogrel through measurement of ADP-induced Akt phosphorylation
Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease
High levels of heparin-platelet factor 4 antibodies in patients with pseudothrombocytopenia
Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis
Human alternatively spliced tissue factor is not secreted and does not trigger coagulation
Role of magnesium in factor XIa catalyzed activation of factor IX
HDL-cholesterol and future risk of venous thromboembolism
Evolution of the fibrinogen γ′ chain
Join ISTH
Corrigendum
Corrigendum